請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43491完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李昆達 | |
| dc.contributor.author | Nien-Chieh Hsiao | en |
| dc.contributor.author | 蕭念杰 | zh_TW |
| dc.date.accessioned | 2021-06-15T02:22:22Z | - |
| dc.date.available | 2009-08-20 | |
| dc.date.copyright | 2009-08-20 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-08-18 | |
| dc.identifier.citation | 1. Kuo IC, Yi FC, Cheong N, Shek LP, Chew FT, Lee BW, Chua KY: Sensitization to Blomia tropicalis and Dermatophagoides pteronyssinus-a comparative study between Singapore and Taiwan. Asian Pac J Allergy Immunol 1999, 17(3):179-188.
2. Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM: Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002, 129(1):1-18. 3. Chapman MD, Rowntree S, Mitchell EB, Di Prisco de Fuenmajor MC, Platts-Mills TA: Quantitative assessments of IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis. J Allergy Clin Immunol 1983, 72(1):27-33. 4. Platts-Mills TA, Chapman MD: Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol 1987, 80(6):755-775. 5. Hewitt CR, Brown AP, Hart BJ, Pritchard DI: A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995, 182(5):1537-1544. 6. Takai T, Kato T, Ota M, Yasueda H, Kuhara T, Okumura K, Ogawa H: Recombinant Der p 1 and Der f 1 with in vitro enzymatic activity to cleave human CD23, CD25 and alpha1-antitrypsin, and in vivo IgE-eliciting activity in mice. Int Arch Allergy Immunol 2005, 137(3):194-200. 7. Sakata Y, Arima K, Takai T, Sakurai W, Masumoto K, Yuyama N, Suminami Y, Kishi F, Yamashita T, Kato T et al: The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem 2004, 279(7):5081-5087. 8. de Halleux S, Stura E, VanderElst L, Carlier V, Jacquemin M, Saint-Remy JM: Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen. J Allergy Clin Immunol 2006, 117(3):571-576. 9. Ogawa T, Takai T, Kato T, Kikuchi Y, Niyonsaba F, Ikeda S, Okumura K, Ogawa H: Upregulation of the release of granulocyte-macrophage colony-stimulating factor from keratinocytes stimulated with cysteine protease activity of recombinant major mite allergens, Der f 1 and Der p 1. Int Arch Allergy Immunol 2008, 146(1):27-35. 10. Heymann PW, Chapman MD, Aalberse RC, Fox JW, Platts-Mills TA: Antigenic and structural analysis of group II allergens (Der f II and Der p II) from house dust mites (Dermatophagoides spp). J Allergy Clin Immunol 1989, 83(6):1055-1067. 11. van der Zee JS, van Swieten P, Jansen HM, Aalberse RC: Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1. J Allergy Clin Immunol 1988, 81(5 Pt 1):884-896. 12. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, Chapman MD, Arruda LK: Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 2002, 32(9):1323-1328. 13. Hales BJ, Shen H, Thomas WR: Cytokine responses to Der p 1 and Der p 7: house dust mite allergens with different IgE-binding activities. Clin Exp Allergy 2000, 30(7):934-943. 14. Hales BJ, Hazell LA, Smith W, Thomas WR: Genetic variation of Der p 2 allergens: effects on T cell responses and immunoglobulin E binding. Clin Exp Allergy 2002, 32(10):1461-1467. 15. Cain G, Elderfield AJ, Green R, Smillie FI, Chapman MD, Custovic A, Woodcock A: The effect of dry heat on mite, cat, and dog allergens. Allergy 1998, 53(12):1213-1215. 16. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P: Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000, 290(5500):2298-2301. 17. Thomas WR, Chua KY: The major mite allergen Der p 2 - a secretion of the male mite reproductive tract. Clinical and Experimental Allergy 1995, 25(7):667-669. 18. Nishiyama C, Yuuki T, Takai T, Okumura Y, Okudaira H: Determination of three disulfide bonds in a major house dust mite allergen, Der f II. Int Arch Allergy Immunol 1993, 101(2):159-166. 19. Smith AM, Chapman MD: Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol Immunol 1996, 33(4-5):399-405. 20. Mueller GA, Benjamin DC, Rule GS: Tertiary structure of the major house dust mite allergen Der p 2: sequential and structural homologies. Biochemistry 1998, 37(37):12707-12714. 21. Derewenda U, Li J, Derewenda Z, Dauter Z, Mueller GA, Rule GS, Benjamin DC: The crystal structure of a major dust mite allergen Der p 2, and its biological implications. J Mol Biol 2002, 318(1):189-197. 22. Mantyjarvi R, Rautiainen J, Virtanen T: Lipocalins as allergens. Biochim Biophys Acta 2000, 1482(1-2):308-317. 23. Asero R, Mistrello G, Roncarolo D, Amato S, van Ree R: A case of allergy to beer showing cross-reactivity between lipid transfer proteins. Ann Allergy Asthma Immunol 2001, 87(1):65-67. 24. Furmonaviciene R, Shakib F: The molecular basis of allergenicity: comparative analysis of the three dimensional structures of diverse allergens reveals a common structural motif. Mol Pathol 2001, 54(3):155-159. 25. Thomas WR, Smith W: House-dust-mite allergens. Allergy 1998, 53(9):821-832. 26. Weiner HL: Oral tolerance. Proc Natl Acad Sci U S A 1994, 91(23):10762-10765. 27. Weiner HL: Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 1997, 48:341-351. 28. Benson JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, Whitacre CC: Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol 1999, 162(10):6247-6254. 29. Wardrop RM, 3rd, Whitacre CC: Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm Res 1999, 48(3):106-119. 30. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993, 261(5129):1727-1730. 31. Pinzon-Charry A: Edible malaria vaccines that bear fruit. Med Hypotheses 2007, 68(5):1180-1181. 32. Takagi H, Hiroi T, Yang L, Tada Y, Yuki Y, Takamura K, Ishimitsu R, Kawauchi H, Kiyono H, Takaiwa F: A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci U S A 2005, 102(48):17525-17530. 33. Hiroi T, Takaiwa F: Peptide immunotherapy for allergic diseases using a rice-based edible vaccine. Curr Opin Allergy Clin Immunol 2006, 6(6):455-460. 34. Takagi H, Hirose S, Yasuda H, Takaiwa F: Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens. J Agric Food Chem 2006, 54(26):9901-9905. 35. Takaiwa F: A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy. Immunol Allergy Clin North Am 2007, 27(1):129-139. 36. Yang L, Suzuki K, Hirose S, Wakasa Y, Takaiwa F: Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Plant Biotechnol J 2007, 5(6):815-826. 37. Yang L, Kajiura H, Suzuki K, Hirose S, Fujiyama K, Takaiwa F: Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy. Biochem Biophys Res Commun 2008, 365(2):334-339. 38. Li HY, Ramalingam S, Chye ML: Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines. Exp Biol Med (Maywood) 2006, 231(8):1346-1352. 39. Zhang H, Zhang X, Liu M, Zhang J, Li Y, Zheng CC: Expression and characterization of Helicobacter pylori heat-shock protein A (HspA) protein in transgenic tobacco (Nicotiana tabacum) plants. Biotechnol Appl Biochem 2006, 43(Pt 1):33-38. 40. Lacorte C, Lohuis H, Goldbach R, Prins M: Assessing the expression of chicken anemia virus proteins in plants. Virus Res 2007, 129(2):80-86. 41. Zhang X, Buehner NA, Hutson AM, Estes MK, Mason HS: Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 2006, 4(4):419-432. 42. Jiang XL, He ZM, Peng ZQ, Qi Y, Chen Q, Yu SY: Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice. Transgenic Res 2007, 16(2):169-175. 43. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS: An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26(15):1846-1854. 44. Lal P, Ramachandran VG, Goyal R, Sharma R: Edible vaccines: current status and future. Indian J Med Microbiol 2007, 25(2):93-102. 45. Hansen E, Kawashima CG: Delivery of immunoprophylactics in transgenic plants: current status. BioDrugs 2000, 13(6):381-390. 46. Streatfield SJ: Mucosal immunization using recombinant plant-based oral vaccines. Methods 2006, 38(2):150-157. 47. Giudice EL, Campbell JD: Needle-free vaccine delivery. Adv Drug Deliv Rev 2006, 58(1):68-89. 48. Thomas WR, Stewart GA, Simpson RJ, Chua KY, Plozza TM, Dilworth RJ, Nisbet A, Turner KJ: Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli. Int Arch Allergy Appl Immunol 1988, 85(1):127-129. 49. Koutz P, Davis GR, Stillman C, Barringer K, Cregg J, Thill G: Structural comparison of the Pichia pastoris alcohol oxidase genes. Yeast 1989, 5(3):167-177. 50. Jacquet A, Haumont M, Massaer M, Daminet V, Garcia L, Mazzu P, Jacobs P, Bollen A: Biochemical and immunological characterization of a recombinant precursor form of the house dust mite allergen Der p 1 produced by Drosophila cells. Clin Exp Allergy 2000, 30(5):677-684. 51. Takai T, Mineki R, Nakazawa T, Takaoka M, Yasueda H, Murayama K, Okumura K, Ogawa H: Maturation of the activities of recombinant mite allergens Der p 1 and Der f 1, and its implication in the blockade of proteolytic activity. FEBS Lett 2002, 531(2):265-272. 52. van Oort E, de Heer PG, van Leeuwen WA, Derksen NI, Muller M, Huveneers S, Aalberse RC, van Ree R: Maturation of Pichia pastoris-derived recombinant pro-Der p 1 induced by deglycosylation and by the natural cysteine protease Der p 1 from house dust mite. Eur J Biochem 2002, 269(2):671-679. 53. Massaer M, Mazzu P, Haumont M, Magi M, Daminet V, Bollen A, Jacquet A: High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage. Int Arch Allergy Immunol 2001, 125(1):32-43. 54. Jacquet A, Magi M, Petry H, Bollen A: High-level expression of recombinant house dust mite allergen Der p 1 in Pichia pastoris. Clin Exp Allergy 2002, 32(7):1048-1053. 55. Gough L, Schulz O, Sewell HF, Shakib F: The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J Exp Med 1999, 190(12):1897-1902. 56. Kikuchi Y, Takai T, Kuhara T, Ota M, Kato T, Hatanaka H, Ichikawa S, Tokura T, Akiba H, Mitsuishi K et al: Crucial commitment of proteolytic activity of a purified recombinant major house dust mite allergen Der p1 to sensitization toward IgE and IgG responses. J Immunol 2006, 177(3):1609-1617. 57. van Oort E, Lerouge P, de Heer PG, Seveno M, Coquet L, Modderman PW, Faye L, Aalberse RC, van Ree R: Substitution of Pichia pastoris-derived recombinant proteins with mannose containing O- and N-linked glycans decreases specificity of diagnostic tests. Int Arch Allergy Immunol 2004, 135(3):187-195. 58. Takai T, Mizuuchi E, Kikuchi Y, Nagamune T, Okumura K, Ogawa H: Glycosylation of recombinant proforms of major house dust mite allergens Der p 1 and Der f 1 decelerates the speed of maturation. Int Arch Allergy Immunol 2006, 139(3):181-187. 59. Chua KY, Dilworth RJ, Thomas WR: Expression of Dermatophagoides pteronyssinus allergen, Der p II, in Escherichia coli and the binding studies with human IgE. Int Arch Allergy Appl Immunol 1990, 91(2):124-129. 60. Takai T, Takaoka M, Yasueda H, Okumura K, Ogawa H: Dilution method to refold bacterially expressed recombinant Der f 2 and Der p 2 to exhibit the secondary structure and histamine-releasing activity of natural allergens. Int Arch Allergy Immunol 2005, 137(1):1-8. 61. Mueller GA, Smith AM, Williams DC, Jr., Hakkaart GA, Aalberse RC, Chapman MD, Rule GS, Benjamin DC: Expression and secondary structure determination by NMR methods of the major house dust mite allergen Der p 2. J Biol Chem 1997, 272(43):26893-26898. 62. Hitzeman RA, Hagie FE, Levine HL, Goeddel DV, Ammerer G, Hall BD: Expression of a human gene for interferon in yeast. Nature 1981, 293(5835):717-722. 63. Hakkaart GA, Harmsen MM, Chua KY, Thomas WR, Aalberse RC, Van Ree R: Expression of the house dust mite allergen Der p 2 in the baker's yeast Saccharomyces cerevisiae. Clin Exp Allergy 1998, 28(1):45-52. 64. Ho H: The effects of oral delivery of recombinant Der p 2 allergen on airway inflammation in murine model of asthma. Master thesis. Graduate institute of immunology, National Taiwan University. 2002. 65. Conde R, Cueva R, Pablo G, Polaina J, Larriba G: A search for hyperglycosylation signals in yeast glycoproteins. J Biol Chem 2004, 279(42):43789-43798. 66. Lin W-Y: Production of recombinant Der p 2 allergen protein in tobacco cells by fed-batch culture. Master thesis, Institute of Microbiology and Biochemistry. National Taiwan University. 2007. 67. Graciet E, Gans P, Wedel N, Lebreton S, Camadro JM, Gontero B: The small protein CP12: a protein linker for supramolecular complex assembly. Biochemistry 2003, 42(27):8163-8170. 68. Wu SC, Castellino FJ, Wong SL: A fast-acting, modular-structured staphylokinase fusion with Kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy. J Biol Chem 2003, 278(20):18199-18206. 69. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T: Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng 2001, 14(8):529-532. 70. Higgins DR, Cregg, J.M., and NetLibrary, I.: Pichia protocols (Totowa, N.J.: Humana Press). 1998. 71. Abdulaev NG, Popp MP, Smith WC, Ridge KD: Functional expression of bovine opsin in the methylotrophic yeast Pichia pastoris. Protein Expr Purif 1997, 10(1):61-69. 72. Bretthauer RK, Castellino FJ: Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem 1999, 30 ( Pt 3):193-200. 73. Khatri NK, Hoffmann F: Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris. Appl Microbiol Biotechnol 2006, 72(3):492-498. 74. Cregg JM, Vedvick TS, Raschke WC: Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology (N Y) 1993, 11(8):905-910. 75. Cregg JM, Madden KR, Barringer KJ, Thill GP, Stillman CA: Functional characterization of the two alcohol oxidase genes from the yeast Pichia pastoris. Mol Cell Biol 1989, 9(3):1316-1323. 76. Gemmill TR, Trimble RB: Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim Biophys Acta 1999, 1426(2):227-237. 77. Grinna LS, Tschopp JF: Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast 1989, 5(2):107-115. 78. Van Arsdell SW, Stetler GL, Thorner J: The yeast repeated element sigma contains a hormone-inducible promoter. Mol Cell Biol 1987, 7(2):749-759. 79. Tsai M-C: Expression of recombinant Der p 1 and 2 fusion allergen by Pichia pastoris. Master Thesis. Institute of Microbology and Biochemistry. National Taiwan University. 2008. 80. Becker DM, Guarente L: High-efficiency transformation of yeast by electroporation. Methods Enzymol 1991, 194:182-187. 81. Chang DC: Guide to electroporation and electrofusion (San Diego: Academic Press). 1992. 82. Daly R, Hearn MT: Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 2005, 18(2):119-138. 83. Clare JJ, Romanos MA, Rayment FB, Rowedder JE, Smith MA, Payne MM, Sreekrishna K, Henwood CA: Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 1991, 105(2):205-212. 84. Chevigne A, Barumandzadeh R, Groslambert S, Cloes B, Dehareng D, Filee P, Marx JC, Frere JM, Matagne A, Jacquet A et al: Relationship between propeptide pH unfolding and inhibitory ability during ProDer p 1 activation mechanism. J Mol Biol 2007, 374(1):170-185. 85. Zhang J, Saint-Remy JM, Garrod DR, Robinson C: Comparative enzymology of native and recombinant house dust mite allergen Der p 1. Allergy 2009, 64(3):469-477. 86. Takai T, Kato T, Yasueda H, Okumura K, Ogawa H: Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains. J Allergy Clin Immunol 2005, 115(3):555-563. 87. Chung C-C: Study on expression of the house dust mite allergen Der p 2 in Flammulina velutipes. Master Thesis. Institute of Microbology and Biochemistry. National Taiwan University. 2006. 88. Yamamoto Y, Watabe S, Kageyama T, Takahashi SY: Proregion of Bombyx mori cysteine proteinase functions as an intramolecular chaperone to promote proper folding of the mature enzyme. Arch Insect Biochem Physiol 1999, 42(3):167-178. 89. Wiederanders B: The function of propeptide domains of cysteine proteinases. Adv Exp Med Biol 2000, 477:261-270. 90. Asturias JA, Ibarrola I, Arilla MC, Vidal C, Ferrer A, Gamboa PM, Vinuela JE, Sanz ML, Andreu C, Martinez A: Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. Clin Exp Allergy 2009, 39(7):1088-1098. 91. Kobayashi K, Kuwae S, Ohya T, Ohda T, Ohyama M, Ohi H, Tomomitsu K, Ohmura T: High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J Biosci Bioeng 2000, 89(1):55-61. 92. Brierley RA: Secretion of recombinant human insulin-like growth factor I (IGF-I). Methods Mol Biol 1998, 103:149-177. 93. Jahic M, Gustavsson M, Jansen AK, Martinelle M, Enfors SO: Analysis and control of proteolysis of a fusion protein in Pichia pastoris fed-batch processes. J Biotechnol 2003, 102(1):45-53. 94. Van Den Hazel HB, Kielland-Brandt MC, Winther JR: Review: biosynthesis and function of yeast vacuolar proteases. Yeast 1996, 12(1):1-16. 95. Jayanta Sinha BAP, Mehmet Inan, Michael Meagher: Causes of Proteolytic Degradation of Secreted Recombinant Proteins Produced in ethylotrophic Yeast Pichia pastoris:Case Study With Recombinant Ovine Interferon-T. University of Nebraska-Lincoln. 2004. 96. Gustavsson M, Lehtio J, Denman S, Teeri TT, Hult K, Martinelle M: Stable linker peptides for a cellulose-binding domain-lipase fusion protein expressed in Pichia pastoris. Protein Eng 2001, 14(9):711-715. 97. Holmquist M, Tessier DC, Cygler M: High-level production of recombinant Geotrichum candidum lipases in yeast Pichia pastoris. Protein Expr Purif 1997, 11(1):35-40. 98. Schmidt M, Hoffman DR: Expression systems for production of recombinant allergens. Int Arch Allergy Immunol 2002, 128(4):264-270. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43491 | - |
| dc.description.abstract | 家居塵蟎 (HDM) 是引起呼吸系統免疫症狀的主要元兇。塵蟎中 Der p 1及 Der p 2 為造成氣喘、異位性皮膚炎等免疫反應的過敏原。為了提供發展口服耐受性的材料,本實驗室先前於酵母菌 Pichia pastoris X-33,已建構以 pPICZαA 為表現載體,並以α-螺旋做為 linker 連接 Der p 1 與 Der p 2 的融合過敏原基因。本研究利用 site-directed mutagenesis ,將融合過敏原 Der p 1 序列上第52號天門冬醯胺置換成麩醯胺,以去除醣基化現象。此質體經電轉形進入 Pichia pastoris X-33 ,並利用針對 Der p 2 之三明治酵素免疫分析法篩選出一株表現量最高的 Mut+ 菌株進行表現研究。此重組融合過敏原蛋白於 Hinton 氏搖瓶中培養並經甲醇誘導 120 小時,表現量為 15 µg/mL 。在 Bioflo110 發酵槽中進行細胞高密度培養,其細胞濕重可達 325 g/L ,融合過敏原蛋白質的產量於培養 126 小時為 127 mg/L ,但隨著培養時間增加,融合過敏原表現量呈現下降之趨勢,至 162 小時為 58 mg/L。推測可能受到培養基中存在之蛋白酶之水解。因此,另以小量培養之上清液加入重組 Der p 2,評估重組蛋白質被水解程度。結果顯示,在不添加任何蛋白酶抑制劑下48小時 rDer p 2 幾乎被完全降解;若添加 1 % casamino acids,rDer p 2 殘留40%。所以我們將針對如何抑制培養基之蛋白酶活性,以避免重組融合過敏原蛋白被降解所造成表現量降低之問題。 | zh_TW |
| dc.description.abstract | House dust mite (HDM) is major source that elicit airway allergic symptoms. In HDM, allergens Der p 1 and Der p 2 show the most significant effect on allergic responses including asthma and atopic dermatisis. In our previous study, gene of Der p 1 and Der p 2 was linked by an α-helix linker in a secretable vector, pPICZαA, and was expressed by the system of Pichia pastoris X-33. In this study, in order to avoid incorrect of glycosylation of rDer p 1, we used site-directed mutagenesis technology to replace the glycosylation site, Asn52, with Gln on the polypeptide sequence of the fusion protein. With an ELISA assay specific to Der p 2, we selected a Mut+ strain which showed the highest productivity for further productivity research. The production yield of fusion protein was 15 µg/ml in Hinton’s flasks after 120 h of culture and methanol induction. A high cell density culture in the Bioflo110 fermentor was achieved with 325 g/L wet biomass, and 127 mg/L fusion allergen production at 126 hours. However, the fusion allergen in the medium dropped with the increase of culture time, and the productivity of fusion allergen was 58 mg/L at 162 h. In orer to reveal whether this phenomenon was caused by degradeation by protease in the culture medium, rDer p 2 was added to the supernatant of cultured medium of the transformed Pichia pastoris, to quantify the residual fusion protein in the medium. Compared to the group that rDer p 2 was almost degraded after 48 h of treatment, 40 % fusion protein remained in the medium was observed in the group which was added 1 % casamino acids. It shows fusion protein was degraded during fermentation process. Therefore, to overcome the problem caused by protease in fermentation is the most important issue in the next step. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T02:22:22Z (GMT). No. of bitstreams: 1 ntu-98-R96B47112-1.pdf: 2175572 bytes, checksum: d88f0ebcb823294b9b17641357ce42e8 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 口試委員審定 Ⅰ
謝誌 Ⅱ 中文摘要 Ⅲ 英文摘要 Ⅳ 縮寫表 Ⅵ 專有名詞中英文對照表 Ⅶ 目錄 Ⅷ 圖表目錄 ⅩⅠ 第一章 前言 1 1.1 屋塵蟎過敏原 2 1.1.1 過敏原 Der p 1 3 1.1.2 過敏原 Der p 2 3 1.2 減敏療法 5 1.2.1 屋塵蟎萃取物 5 1.2.2 皮下注射 5 1.2.3 口服耐受性 6 1.2.4 口服式疫苗 6 1.3 不同宿主中表現重組的 Der p 1 及 Der p 2 7 1.3.1 表現重組的 Der p 1 8 1.3.1.1 E. coli 中表現重組 Der p 1 8 1.3.1.2 昆蟲細胞中表現重組 Der p 1 8 1.3.1.3 哺乳動物細胞中表現重組 Der p 1 9 1.3.1.4 Pichia pastoris 中表現重組 Der p 1 9 1.3.2 表現重組的 Der p 2 10 1.3.2.1 E. coli 中表現重組 Der p 2 10 1.3.2.2 酵母菌中表現重組 Der p 2 11 1.3.2.3 植物細胞中表現重組 Der p 2 11 1.4 融合過敏原蛋白和蛋白質linker 11 1.5 Pichia pastoris 12 1.5.1 AOX1 啟動子 13 1.5.2 醣基化 14 1.5.2.1 N型醣基化 15 1.5.2.2 O型醣基化 15 1.6 研究目的 16 1.7 研究架構 18 第二章 材料與方法 19 2.1 微生物與載體 20 2.2 建構 P. pastoris 表現載體 20 2.2.1 Site-directed mutation 之製作 21 2.2.2 質體 DNA 製備 22 2.2.3 酵母菌電穿孔法 23 2.2.4 酵母菌 colony PCR 分析 24 2.3 選擇適當的表現菌株 25 2.3.1 篩選 Mut+ 表現菌株 25 2.3.2 Zeocin 篩選出高拷貝數 (high copy number) 菌株26 2.3.3 小量表現篩選出高表現量菌株 26 2.4 Hinton 氏搖瓶培養 26 2.4.1 評估 casamino acids 對蛋白水解酶活性的抑制效果27 2.5 發酵槽培養 28 2.5.1 HPLC分析甘油及甲醇濃度 29 2.6 蛋白質定量 29 2.7 製備 rDer p 2 29 2.8 三明治酵素免疫分析法 30 2.9 西方墨點轉漬法 31 2.9.1 Der p 2 西方墨點轉漬法 31 2.9.2 His Tag 西方墨點轉漬法 31 第三章 結果 33 3.1 建構融和過敏原基因 34 3.2 選擇高表現量菌株 35 3.3 乾油及甲醇之標準曲線 36 3.4 Hinton氏搖瓶及發酵槽培養 36 3.5 西方墨點轉漬法 37 3.6 評估 casamino acids 對蛋白酶活性的抑制效果 38 第四章 討論與結論 40 圖表 45 參考文獻 67 附錄 77 | |
| dc.language.iso | zh-TW | |
| dc.subject | N型醣基化 | zh_TW |
| dc.subject | 畢赤酵母 | zh_TW |
| dc.subject | α-螺旋 | zh_TW |
| dc.subject | α-訊息序列 | zh_TW |
| dc.subject | 融合過敏原蛋白 | zh_TW |
| dc.subject | Der p 1 | zh_TW |
| dc.subject | Der p 2 | zh_TW |
| dc.subject | Pichia pastoris | en |
| dc.subject | Der p 1 | en |
| dc.subject | fusion allergnen | en |
| dc.subject | α-factor singal sequence | en |
| dc.subject | α-helix | en |
| dc.subject | N-glycosylation | en |
| dc.subject | Der p 2 | en |
| dc.title | 以 Pichia pastoris 生產重組塵蟎過敏原 Der p 1, 2 融合蛋白 | zh_TW |
| dc.title | Production of recombinant Der p 1 and 2 fusion house dust mite allergen by Pichia pastoris | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 蘇遠志,江伯倫,林璧鳳,黃慶璨 | |
| dc.subject.keyword | 畢赤酵母,α-螺旋,α-訊息序列,融合過敏原蛋白,Der p 1,Der p 2,N型醣基化, | zh_TW |
| dc.subject.keyword | Pichia pastoris,α-helix,α-factor singal sequence,fusion allergnen,Der p 1,Der p 2,N-glycosylation, | en |
| dc.relation.page | 84 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-08-19 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 微生物與生化學研究所 | zh_TW |
| 顯示於系所單位: | 微生物學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 2.12 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
